The start predicts the finish: Factors associated with antidepressant nonadherence among older veterans during the acute and maintenance treatment phases

Lauren B. Gerlach, Claire Chiang, Helen C. Kales

Research output: Contribution to journalArticle

Abstract

Objective: To best prevent depression relapse and reduce recurrence, an understanding of the factors associated with continued maintenance treatment is needed. This study compared factors associated with antidepressant nonadherence during the acute (ie, during the first 4 months) and maintenance (ie, during 12 months) treatment phase among older veterans with depression. Methods: In this prospective, observational study of 278 older veterans with depression (Patient Health Questionnaire-9 score ≥ 5), patients had been given a new antidepressant prescription between 2008 and 2011. Participants completed initial and followup interviews at 4 and 12 months. Medication adherence was assessed by the Brief Medication Questionnaire. A generalized estimating equation was used to determine patient factors associated with nonadherence at each time point. Results: Nearly a third of veterans were nonadherent at 4- and 12-month follow-up. In adjusted analyses, nonadherence was significantly associated with African American race (adjusted odds ratio [AOR] = 2.69, 95% CI, 1.30-5.57; P= .01), being unmarried (AOR = 1.84; 95% CI, 1.16-2.92; P= .049), greater medical comorbidity (AOR = 1.30; 95% CI, 1.13-1.49; P< .001), functional impairment (AOR = 1.34; 95% CI, 1.10-1.63; P= .01), and self-reported side effects (AOR = 2.48; 95% CI, 1.57-3.94; P< .001) at both 4 and 12 months. Depression or anxiety severity did not predict antidepressant adherence at either time point. Conclusions: Rates of and factors associated with antidepressant nonadherence were similar at 4 and 12 months. Further work is needed to develop tailored treatment programs to engage older veterans at higher risk of nonadherence in the early treatment period, which may ultimately help to both achieve remission and reduce relapse and recurrence.

Original languageEnglish (US)
Article number18m12476
JournalJournal of Clinical Psychiatry
Volume80
Issue number3
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Fingerprint

Veterans
Antidepressive Agents
Odds Ratio
Depression
Recurrence
Therapeutics
Medication Adherence
African Americans
Observational Studies
Prescriptions
Comorbidity
Anxiety
Maintenance
Prospective Studies
Interviews
Health
Surveys and Questionnaires

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

@article{6812ec39918040b39bd008b6b1d42034,
title = "The start predicts the finish: Factors associated with antidepressant nonadherence among older veterans during the acute and maintenance treatment phases",
abstract = "Objective: To best prevent depression relapse and reduce recurrence, an understanding of the factors associated with continued maintenance treatment is needed. This study compared factors associated with antidepressant nonadherence during the acute (ie, during the first 4 months) and maintenance (ie, during 12 months) treatment phase among older veterans with depression. Methods: In this prospective, observational study of 278 older veterans with depression (Patient Health Questionnaire-9 score ≥ 5), patients had been given a new antidepressant prescription between 2008 and 2011. Participants completed initial and followup interviews at 4 and 12 months. Medication adherence was assessed by the Brief Medication Questionnaire. A generalized estimating equation was used to determine patient factors associated with nonadherence at each time point. Results: Nearly a third of veterans were nonadherent at 4- and 12-month follow-up. In adjusted analyses, nonadherence was significantly associated with African American race (adjusted odds ratio [AOR] = 2.69, 95{\%} CI, 1.30-5.57; P= .01), being unmarried (AOR = 1.84; 95{\%} CI, 1.16-2.92; P= .049), greater medical comorbidity (AOR = 1.30; 95{\%} CI, 1.13-1.49; P< .001), functional impairment (AOR = 1.34; 95{\%} CI, 1.10-1.63; P= .01), and self-reported side effects (AOR = 2.48; 95{\%} CI, 1.57-3.94; P< .001) at both 4 and 12 months. Depression or anxiety severity did not predict antidepressant adherence at either time point. Conclusions: Rates of and factors associated with antidepressant nonadherence were similar at 4 and 12 months. Further work is needed to develop tailored treatment programs to engage older veterans at higher risk of nonadherence in the early treatment period, which may ultimately help to both achieve remission and reduce relapse and recurrence.",
author = "Gerlach, {Lauren B.} and Claire Chiang and Kales, {Helen C.}",
year = "2019",
month = "1",
day = "1",
doi = "10.4088/JCP.18m12476",
language = "English (US)",
volume = "80",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "3",

}

TY - JOUR

T1 - The start predicts the finish

T2 - Factors associated with antidepressant nonadherence among older veterans during the acute and maintenance treatment phases

AU - Gerlach, Lauren B.

AU - Chiang, Claire

AU - Kales, Helen C.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective: To best prevent depression relapse and reduce recurrence, an understanding of the factors associated with continued maintenance treatment is needed. This study compared factors associated with antidepressant nonadherence during the acute (ie, during the first 4 months) and maintenance (ie, during 12 months) treatment phase among older veterans with depression. Methods: In this prospective, observational study of 278 older veterans with depression (Patient Health Questionnaire-9 score ≥ 5), patients had been given a new antidepressant prescription between 2008 and 2011. Participants completed initial and followup interviews at 4 and 12 months. Medication adherence was assessed by the Brief Medication Questionnaire. A generalized estimating equation was used to determine patient factors associated with nonadherence at each time point. Results: Nearly a third of veterans were nonadherent at 4- and 12-month follow-up. In adjusted analyses, nonadherence was significantly associated with African American race (adjusted odds ratio [AOR] = 2.69, 95% CI, 1.30-5.57; P= .01), being unmarried (AOR = 1.84; 95% CI, 1.16-2.92; P= .049), greater medical comorbidity (AOR = 1.30; 95% CI, 1.13-1.49; P< .001), functional impairment (AOR = 1.34; 95% CI, 1.10-1.63; P= .01), and self-reported side effects (AOR = 2.48; 95% CI, 1.57-3.94; P< .001) at both 4 and 12 months. Depression or anxiety severity did not predict antidepressant adherence at either time point. Conclusions: Rates of and factors associated with antidepressant nonadherence were similar at 4 and 12 months. Further work is needed to develop tailored treatment programs to engage older veterans at higher risk of nonadherence in the early treatment period, which may ultimately help to both achieve remission and reduce relapse and recurrence.

AB - Objective: To best prevent depression relapse and reduce recurrence, an understanding of the factors associated with continued maintenance treatment is needed. This study compared factors associated with antidepressant nonadherence during the acute (ie, during the first 4 months) and maintenance (ie, during 12 months) treatment phase among older veterans with depression. Methods: In this prospective, observational study of 278 older veterans with depression (Patient Health Questionnaire-9 score ≥ 5), patients had been given a new antidepressant prescription between 2008 and 2011. Participants completed initial and followup interviews at 4 and 12 months. Medication adherence was assessed by the Brief Medication Questionnaire. A generalized estimating equation was used to determine patient factors associated with nonadherence at each time point. Results: Nearly a third of veterans were nonadherent at 4- and 12-month follow-up. In adjusted analyses, nonadherence was significantly associated with African American race (adjusted odds ratio [AOR] = 2.69, 95% CI, 1.30-5.57; P= .01), being unmarried (AOR = 1.84; 95% CI, 1.16-2.92; P= .049), greater medical comorbidity (AOR = 1.30; 95% CI, 1.13-1.49; P< .001), functional impairment (AOR = 1.34; 95% CI, 1.10-1.63; P= .01), and self-reported side effects (AOR = 2.48; 95% CI, 1.57-3.94; P< .001) at both 4 and 12 months. Depression or anxiety severity did not predict antidepressant adherence at either time point. Conclusions: Rates of and factors associated with antidepressant nonadherence were similar at 4 and 12 months. Further work is needed to develop tailored treatment programs to engage older veterans at higher risk of nonadherence in the early treatment period, which may ultimately help to both achieve remission and reduce relapse and recurrence.

UR - http://www.scopus.com/inward/record.url?scp=85063957133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063957133&partnerID=8YFLogxK

U2 - 10.4088/JCP.18m12476

DO - 10.4088/JCP.18m12476

M3 - Article

C2 - 30920188

AN - SCOPUS:85063957133

VL - 80

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - 3

M1 - 18m12476

ER -